Question 1

What is Liminatus Pharma?

Accepted Answer

Liminatus Pharma is a Entity.

Question 2

How often does Liminatus Pharma appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 7 articles.

Question 3

When was Liminatus Pharma first tracked by Ergen?

Accepted Answer

First tracked on May 22, 2026.

Question 4

When was Liminatus Pharma last mentioned in news?

Accepted Answer

Last active on May 22, 2026.

Question 5

What is Liminatus Pharma's current news sentiment?

Accepted Answer

Aggregate sentiment score: -90 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Liminatus Pharma in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving Liminatus Pharma?

Accepted Answer

Liminatus Pharma Nasdaq Delisting Notice (May 22, 2026, 7 articles).

Question 8

How did the "Liminatus Pharma Nasdaq Delisting Notice" event impact Liminatus Pharma?

Accepted Answer

Liminatus Pharma received a delisting notice from Nasdaq-100 due to non-compliance with listing rules, which will lead to the suspension of its stock trading unless an appeal is successful. This event significantly impacts its ability to raise capital and its public market valuation.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.